… with an inhaled corticosteroid (ICS). Although prior studies found the highest risk of adrenal
… might be explained by a channelling bias and concomitant exposure to oral corticosteroids. …

… inhaled corticosteroids for a median of 6 years. The researchers found a significant inverse
relation between cumulative inhaled corticosteroid dose … use of inhaled corticosteroids, these …

… the use of inhaled corticosteroids (ICS). We aimed to ascertain the risk of upper respiratory
tract infection (URTI) with long-term inhaled corticosteroid use among patients with asthma. …

… Inhaled corticosteroid (ICS) use could decrease local immunity of the lung. Concerns have
been raised regarding the risk of … . Inhaled corticosteroids and risk of tuberculosis in patients …

Background Inhaled corticosteroids (ICS) are commonly used to treat COPD and are associated
with increased risk of pneumonia. The aim of this study was to assess if accumulated …

… Using a Cox proportional hazards model, we determined the relative risk (RR) of relapse ED
visits among users and nonusers of inhaled corticosteroids after discharge from the ED. We …

… Inhaled corticosteroids (ICS) are … risk of pneumonia in COPD patients. But it is controversial.
The objective of this paper is to clarify the associations between ICS treatment and the risk of …

… Our finding that inhaled steroids re¬ duced the risk for asthma … or without inhaled
corticosteroid therapy for obstructive … bronchial reactivity with an inhaled corticosteroid in asthma. …

… risk factors for pneumonia in patients with COPD, but ICS was not associated with pneumonia
in asthmatic patients. Use of inhaled anticholinergics is a risk … on pneumonia risk cannot …

… that inhaled corticosteroids (ICS) may be associated with higher risks of tuberculosis and
pneumonia in patients with COPD. However, it is not known whether ICS increases the risk of …